JAZZ
Jazz Pharmaceuticals
$255.43
+$1.55 (+0.61%)Jul 27, 2026
Key metrics
The numbers that frame JAZZ today
- Market cap
- $16.03B
- P/E (TTM)
- 543.4
- EV / FCF
- 15.1
- Gross margin
- 88%
- EV / Sales
- 4.4
- ROIC
- -0.5%
- Div yield
- 0%
- Debt / equity
- 1.2
- 52wk Low
- $105.00
- 52wk High
- $257.00
Growth
Revenue and earnings trend for JAZZ
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about JAZZ
Is Jazz Pharmaceuticals a good buy?
Yes. Jazz Pharmaceuticals has strong quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Jazz Pharmaceuticals is selling at a fair price.
What is the market capitalization of JAZZ?
Jazz Pharmaceuticals's market capitalization is $16.03B.
What is the P/E ratio for JAZZ stock?
Jazz Pharmaceuticals's current P/E ratio is 543.4.
What is the 52-week high for JAZZ stock?
The 52-week high for Jazz Pharmaceuticals is $257.00. The current close of $255.43 is 0.6% below that high.
What is the 52-week low for JAZZ stock?
The 52-week low for Jazz Pharmaceuticals is $105.00. The current close of $255.43 is 143.3% above that low.
Does JAZZ stock pay dividends?
Jazz Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for JAZZ?
Jazz Pharmaceuticals's Debt / Equity ratio is 1.19.